Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 1905Neoplasms 1528Prostatic Neoplasms 751Colorectal Neoplasms 714Lung Neoplasms 582Motor Activity 391Head and Neck Neoplasms 328Colonic Neoplasms 311Uterine Cervical Neoplasms 297Pain 247Pancreatic Neoplasms 246Anxiety Disorders 220Rectal Neoplasms 213Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 193Stomach Neoplasms 191Polycystic Ovary Syndrome 188Ovarian Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Brain Neoplasms 168Urinary Bladder Neoplasms 165Depression 164Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 137Lymphoma 135Lymphoma, Follicular 128Obesity 127

Interventions

trifluridine tipiracil drug combination 1tipiracil 1Trifluridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Completed × Solid Tumor Cancer × Clear all
NCT07492173 2026-03-25

Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Shandong New Time Pharmaceutical Co., LTD

Phase NA Completed
76 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡